Appeals court: FDA wrongly widened access to abortion pill
August 17, 2023
» Continue to this story on Wall Street Journal
CWN Editor's Note: A federal appeals court has ruled that the Food and Drug Administration acted improperly in broadening access to the abortion pill mifepristone. But the decision does not take the pill off pharmacy shelves.
The Fifth Circuit Court ruled that the FDA did not properly weigh the potential dangers of unsupervised use of the abortion pill.
The Supreme Court has ruled that the the abortion pill should remain available while litigation continues. However the Fifth Circuit ruling makes it more likely that the ultimate decision on the FDA approval will again be made by the Supreme Court.
For all current news, visit our News home page.
All comments are moderated. To lighten our editing burden, only current donors are allowed to Sound Off. If you are a current donor, log in to see the comment form; otherwise please support our work, and Sound Off!
